Search Results - "Ferrari Piquero, JM"

Refine Results
  1. 1

    4CPS-022 Adherence to evolocumab and its impact on LDL cholesterol reduction by Bertran de lis Bartolome, B, González Sevilla, M, Ferrari Piquero, JM

    “…Background and ImportanceAccording to the latest recommendations, the need to achieve lower cholesterol levels has become more important. Therefore, the use of…”
    Get full text
    Journal Article
  2. 2

    4CPS-162 Triple whammy drug-drug interaction: clinical relevance and results of pharmaceutical intervention by González Gómez, Á, Hernández Ramos, JA, Castro Frontiñán, A, Caro Teller, JM, Canales Siguero, MD, Ferrari Piquero, JM

    “…Background and ImportanceAcute kidney injury (AKI) is a highly prevalent condition among inpatients, usually attributed to pharmacological causes. One of the…”
    Get full text
    Journal Article
  3. 3

    3PC-027 Stability of tacrolimus oral suspension in disposable polypropylene syringe by Hernandez Ramos, JA, Pablos Bravo, S, Rolo, M, Bruni Montero, MA, Gonzalez Gomez, A, Castro Frontiñan, A, Ferrari Piquero, JM

    “…Background and ImportanceWithin the post-operative period following a solid organ transplantation, multidisciplinary teams prioritise tacrolimus administration…”
    Get full text
    Journal Article
  4. 4
  5. 5

    5PSQ-142 Safety of azole antifungals in transplanted patients receiving tacrolimus by Canales, D, Caro Teller, JM, Martínez De La Torre, F, Gonzalez Barrios, I, Hernandez Ramos, JA, Montero, MÁ Bruni, Ferrari Piquero, JM

    “…Background and importancePotential interaction between tacrolimus and azole antifungals is often detected in transplanted patients with fungal colonisation or…”
    Get full text
    Journal Article
  6. 6

    4CPS-028 Experience of ceftaroline use in a third level hospital by Canales, D, Caro Teller, JM, Martínez De La Torre, F, Arrieta Loitegui, M, Rosas, C, Ortiz Pérez, S, Ferrari Piquero, JM

    “…Background and importanceCeftaroline is approved for treating complicated skin and skin structure infections (cSSSI), and community acquired pneumonia (CAP)…”
    Get full text
    Journal Article
  7. 7

    PKP-011 Drug interactions and safety profile in patients treated with riociguat by Sedano, M Nieves, Teller, JM Caro, Redondo, D Fernandez, Perez, S Ortiz, Piquero, JM Ferrari

    “…BackgroundRiociguat is a relatively new drug that has been on the market for a short time. Most of the information available on the drug comes from clinical…”
    Get full text
    Journal Article
  8. 8

    DI-019 Effect and safety of mexiletine on signs and symptoms of myotonic disorders by Fernández-Redondo, D, Olga, S, Marcos, N, Manuel, C Jose, Siria, P, Andrea, L, Isabel, G, Piquero, JM Ferrari, Daniele, A

    “…BackgroundMexiletine, a class 1b antiarrhythmic medication, appears to have some potential for treating muscle stiffness and other symptoms of…”
    Get full text
    Journal Article
  9. 9

    CP-037 Use of sofosbuvir in hepatitis C by Gomez, I, Alioto, D, Cebas, A Lazaro, Sedano, M Nieves, Redondo, D Fernandez, Garrote, O Serrano, Piquero, JM Ferrari

    “…BackgroundHepatitis C is a serious disease with a high prevalence, being the leading cause of liver transplantation. There is now rapid development of new…”
    Get full text
    Journal Article
  10. 10

    CP-136 Effectiveness and safety of axitinib in renal cell carcinoma by Sedano, M Nieves, Teller, JM Caro, Redondo, D Fernandez, Valbuena, I Gómez, Piquero, JM Ferrari

    “…BackgroundAgents targeting the vascular endothelial growth factor receptor (VEGF) pathway may induce many toxicities. The European Medicines Agency (EMA)…”
    Get full text
    Journal Article
  11. 11
  12. 12

    4CPS-026 Dalbavancin off-label use: effectiveness and safety by Arrieta, M, Caro-Teller, JM, Ortiz-Pérez, S, Rosas-Espinoza, C, Canales-Siguero, MD, Martínez De La Torre, F, Ferrari-Piquero, JM

    “…Background and importanceDalbavancin is approved for treating complicated skin and soft tissue infections. However, there is growing evidence that other severe…”
    Get full text
    Journal Article
  13. 13

    Análisis de las interacciones farmacológicas y recomendaciones terapéuticas asociadas a la utilización de isavuconazol by Canales Siguero, Caro Teller, JM, Martínez de la Torre, Ferrari Piquero, JM

    Published in Revista de la OFIL (01-06-2022)
    “…Resumen Objetivos: Identificar, describir las interacciones farmacológicas potenciales de isavuconazol, estudiar el impacto clínico de aquellas más relevantes…”
    Get full text
    Journal Article
  14. 14

    Inducción de remisión con gentamicina y vancomicina oral en enfermedad inflamatoria intestinal de inicio temprano by Sánchez-Sanz, García-Muñoz, Alonso-Pérez, Ferrari-Piquero, JM

    Published in Revista de la OFIL (01-06-2022)
    “…Resumen La enfermedad inflamatoria intestinal de inicio temprano se manifiesta en pacientes pediátricos antes de los 6 años de edad. Habitualmente se asocia a…”
    Get full text
    Journal Article
  15. 15

    Variabilidad en el registro de alergias entre niveles asistenciales by Ortiz Pérez, Caro Teller, JM, González Sevilla, Ferrari Piquero, JM

    Published in Revista de la OFIL (2021)
    “…RESUMEN Objetivo : El objetivo del estudio es comparar el grado de coincidencia en el registro de alergias entre las aplicaciones informáticas de los distintos…”
    Get full text
    Journal Article
  16. 16

    Efectividad y seguridad de daratumumab y carfilzomib en el tratamiento del mieloma múltiple refractario by Rosas Espinoza, Cortijo Cascajares, Goyache Goñi, MP, Arrieta Loitegui, Ferrari Piquero, JM

    Published in Revista de la OFIL (2021)
    “…RESUMEN Objetivos: El objetivo del estudio es evaluar la efectividad y seguridad de daratumumab y carfilzomib en práctica clínica, y comparar estos resultados…”
    Get full text
    Journal Article
  17. 17

    Efectividad y seguridad de regorafenib y trifluridina/tipiracilo en cáncer colorrectal metastático by Arrieta Loitegui, Lázaro Cebas, Rodríguez Quesada, García Muñoz, Rosas Espinoza, Ferrari Piquero, JM

    Published in Revista de la OFIL (2020)
    “…RESUMEN Objetivos: Comparar la efectividad y seguridad de regorafenib y trifluridina/tipiracilo en pacientes con cáncer de colon metastático en la práctica…”
    Get full text
    Journal Article
  18. 18

    Efectividad y seguridad de ramucirumab en el tratamiento de adenocarcinoma gástrico by Canales Siguero, Cortijo Cascajares, Goyache Goñí, MP, Martínez de la Torre, Ferrari Piquero, JM

    Published in Revista de la OFIL (2021)
    “…RESUMEN Objetivos: Evaluar la efectividad y seguridad de ramucirumab en el tratamiento de adenocarcinoma gástrico metastático (AGM) o adenocarcinoma de la…”
    Get full text
    Journal Article
  19. 19
  20. 20